Jennison Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.74B | Buy |
|
|||||
|
2025
Q1 | $2.45B | Buy |
|
|||||
|
2024
Q4 | $1.74B | Sell |
|
|||||
|
2024
Q3 | $2.58B | Buy |
|
|||||
|
2024
Q2 | $2.2B | Sell |
|
|||||
|
2024
Q1 | $2B | Buy |
|
|||||
|
2023
Q4 | $1.61B | Buy |
|
|||||
|
2023
Q3 | $1.32B | Sell |
|
|||||
|
2023
Q2 | $1.34B | Sell |
|
|||||
|
2023
Q1 | $1.44B | Sell |
|
|||||
|
2022
Q4 | $1.48B | Buy |
|
|||||
|
2022
Q3 | $1.38B | Buy |
|
|||||
|
2022
Q2 | $499M | Buy |
|
|||||
|
2022
Q1 | $91.4M | Sell |
|
|||||
|
2021
Q4 | $172M | Sell |
|
|||||
|
2021
Q3 | $150M | Buy |
|
|||||
|
2021
Q2 | $160M | Buy |
|
|||||
|
2021
Q1 | $154M | Sell |
|
|||||
|
2020
Q4 | $886M | Buy |
|
|||||
|
2020
Q3 | $982M | Sell |
|
|||||
|
2020
Q2 | $1.28B | Buy |
|
|||||
|
2020
Q1 | $1.04B | Buy |
|
|||||
|
2019
Q4 | $782M | Sell |
|
|||||
|
2019
Q3 | $1.01B | Sell |
|
|||||
|
2019
Q2 | $1.16B | Sell |
|
|||||
|
2019
Q1 | $1.25B | Sell |
|
|||||
|
2018
Q4 | $1.15B | Buy |
|
|||||
|
2018
Q3 | $1.2B | Buy |
|
|||||
|
2018
Q2 | $861M | Sell |
|
|||||
|
2018
Q1 | $1.1B | Buy |
|
|||||
|
2017
Q4 | $830M | Sell |
|
|||||
|
2017
Q3 | $915M | Buy |
|
|||||
|
2017
Q2 | $651M | Buy |
|
|||||
|
2017
Q1 | $156M | Buy |
|
|||||
|
2016
Q4 | $96M | Sell |
|
|||||
|
2016
Q3 | $452M | Buy |
|
|||||
|
2016
Q2 | $256M | Buy |
|
|||||
|
2016
Q1 | $83.8M | Sell |
|
|||||
|
2015
Q4 | $262M | Sell |
|
|||||
|
2015
Q3 | $243M | Sell |
|
|||||
|
2015
Q2 | $630M | Sell |
|
|||||
|
2015
Q1 | $773M | Sell |
|
|||||
|
2014
Q4 | $797M | Sell |
|
|||||
|
2014
Q3 | $1.17B | Sell |
|
|||||
|
2014
Q2 | $1.12B | Sell |
|
|||||
|
2014
Q1 | $891M | Sell |
|
|||||
|
2013
Q4 | $1B | Sell |
|
|||||
|
2013
Q3 | $1.06B | Sell |
|
|||||
|
2013
Q2 | $1.37B | Buy |
|